rs1553393940
Variant summary
Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PM1PM2PP2PP3_Moderate
The NM_001244710.2(GFPT1):c.29A>G(p.Tyr10Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000007 in 1,428,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001244710.2 missense
Scores
Clinical Significance
Conservation
Publications
- congenital myasthenic syndrome 12Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), PanelApp Australia, Ambry Genetics, Illumina
- congenital myasthenic syndromes with glycosylation defectInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GFPT1 | NM_001244710.2 | c.29A>G | p.Tyr10Cys | missense_variant | Exon 2 of 20 | ENST00000357308.9 | NP_001231639.1 | |
| GFPT1 | NM_002056.4 | c.29A>G | p.Tyr10Cys | missense_variant | Exon 2 of 19 | NP_002047.2 | ||
| GFPT1 | XM_017003801.2 | c.104A>G | p.Tyr35Cys | missense_variant | Exon 2 of 20 | XP_016859290.1 | ||
| GFPT1 | XM_017003802.3 | c.104A>G | p.Tyr35Cys | missense_variant | Exon 2 of 19 | XP_016859291.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 7.00e-7 AC: 1AN: 1428032Hom.: 0 Cov.: 23 AF XY: 0.00000140 AC XY: 1AN XY: 712396 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Congenital myasthenic syndrome 12 Uncertain:1
In summary, this variant is a novel missense change with uncertain impact on protein function. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a GFPT1-related disease. This sequence change replaces tyrosine with cysteine at codon 10 of the GFPT1 protein (p.Tyr10Cys). The tyrosine residue is highly conserved and there is a large physicochemical difference between tyrosine and cysteine. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at